| Cvs Pharmacy #02413 | |
| 35-26 Francis Lewis Blvd, Flushing, New York 11358 | |
| (718) 353-1571 |
| Name | Cvs Pharmacy #02413 |
|---|---|
| Organization Name | Cvs Albany Llc |
| Location | 35-26 Francis Lewis Blvd, Flushing, New York 11358 |
| Type | Supplier |
| Phone | (718) 353-1571 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
This week's issue of Science features news articles focusing on recent progress on malaria control in Africa and discussing future challenges, including drug resistance.
Omecamtiv mecarbil, a new, investigational heart medication, reduced the risk of heart failure-related events in patients with heart failure with reduced ejection fraction, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.
Today, the National Association of Black Journalists (NABJ) convened the first day of its annual Media Institute on Health: Health Policy and Health Inequities, March 29-31, at the Kaiser Family Foundation's Barbara Jordan Conference Center.
ZIOPHARM Oncology, Inc., a drug development company employing small molecule and synthetic biology approaches to cancer therapy, announced today that the U.S. Food & Drug Administration has accepted the Company's investigational new drug application to begin clinical study of ZIN ATI-001, a novel DNA-based therapeutic candidate also known as Ad-RTS-IL-12 + AL, in oncology.
MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) announced today that its research and diagnostic antibody unit AbD Serotec is active in a new growth area.
› Verified 8 days ago
News Archive
This week's issue of Science features news articles focusing on recent progress on malaria control in Africa and discussing future challenges, including drug resistance.
Omecamtiv mecarbil, a new, investigational heart medication, reduced the risk of heart failure-related events in patients with heart failure with reduced ejection fraction, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.
Today, the National Association of Black Journalists (NABJ) convened the first day of its annual Media Institute on Health: Health Policy and Health Inequities, March 29-31, at the Kaiser Family Foundation's Barbara Jordan Conference Center.
ZIOPHARM Oncology, Inc., a drug development company employing small molecule and synthetic biology approaches to cancer therapy, announced today that the U.S. Food & Drug Administration has accepted the Company's investigational new drug application to begin clinical study of ZIN ATI-001, a novel DNA-based therapeutic candidate also known as Ad-RTS-IL-12 + AL, in oncology.
MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) announced today that its research and diagnostic antibody unit AbD Serotec is active in a new growth area.
› Verified 8 days ago
168 Dme Inc Type: Medicare Supplier Location: 13505 38th Ave, Flushing, New York 11354 Phone: (929) 456-6550 | |
Union Pharmacy Type: Community/Retail Pharmacy Location: 36-32 Union Street, Flushing, New York 11354 Phone: (718) 961-6010 | |
88 Pharmacy Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 136-19 37th Ave, Flushing, New York 11354 Phone: (718) 461-1234 | |
Abc Dme,inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4025 150th St, Flushing, New York 11354 Phone: (718) 460-1004 | |
Ac Pharmacy Type: Pharmacy Location: 15416 Northern Blvd, Flushing, New York 11354 Phone: (718) 886-0060 |